Xiao Yue Selected Research

Xiao Yue Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 07/2010
17	Glioma (Gliomas) 03/2020 - 07/2010
10	Glioblastoma (Glioblastoma Multiforme) 04/2019 - 09/2010
6	Carcinogenesis 09/2012 - 07/2010
4	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 01/2020
3	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2020
2	Wounds and Injuries (Trauma) 02/2022 - 10/2021
2	Breast Neoplasms (Breast Cancer) 11/2018 - 02/2012
1	Infections 08/2022
1	Adenocarcinoma of Lung 01/2022
1	Acidosis 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Kidney Calculi (Kidney Stone) 12/2021
1	Renal Insufficiency (Renal Failure) 12/2021
1	Nephrolithiasis 12/2021
1	Triple Negative Breast Neoplasms 01/2021
1	COVID-19 11/2020
1	Pathologic Processes 01/2020
1	Hyperglycemia 10/2018
1	Lung Neoplasms (Lung Cancer) 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Fever (Fevers) 01/2014
1	Pneumonia (Pneumonitis) 01/2014
1	Radiation Pneumonitis 01/2014
1	Hypersensitivity (Allergy) 06/2013
1	Colorectal Neoplasms (Colorectal Cancer) 02/2012
1	Carcinoma (Carcinomatosis) 02/2012

Drug/Important Bio-Agent (IBA)

10	MicroRNAs (MicroRNA)IBA 03/2020 - 11/2010
9	CateninsIBA 11/2019 - 12/2010
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 02/2022 - 11/2018
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2010
4	LuciferasesIBA 04/2019 - 01/2015
3	Biological ProductsIBA 10/2020 - 01/2020
2	sulforaphaneIBA 02/2016 - 09/2015
2	Temozolomide (Temodar)FDA LinkGeneric 02/2016 - 09/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015 - 01/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2012 - 10/2011
2	Small Interfering RNA (siRNA)IBA 12/2010 - 09/2010
1	Lysine (L-Lysine)FDA Link 08/2022
1	Leucine (L-Leucine)FDA Link 08/2022
1	PowdersIBA 08/2022
1	Therapeutic UsesIBA 08/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Protein CoronaIBA 01/2022
1	Fluvastatin FDA Link 01/2022
1	AcidsIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	CreatinineIBA 12/2021
1	Ethylene Glycol (Monoethylene Glycol)IBA 12/2021
1	Calcium OxalateIBA 12/2021
1	NitrogenIBA 12/2021
1	Drinking WaterIBA 12/2021
1	Urea (Carbamide)FDA LinkGeneric 12/2021
1	Long Noncoding RNAIBA 01/2021
1	Competitive Endogenous RNAIBA 11/2020
1	KinesinsIBA 11/2020
1	Fetal Proteins (Fetoprotein)IBA 10/2020
1	AlbuminsIBA 10/2020
1	BilirubinIBA 10/2020
1	Cathepsin CIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	NAD (NADH)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 04/2019
1	Adenosine Triphosphate (ATP)IBA 04/2019
1	Heme Oxygenase-1IBA 11/2018
1	Epirubicin (Ellence)FDA LinkGeneric 11/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018
1	BerberineIBA 10/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2015
1	TensinsIBA 10/2015
1	InterleukinsIBA 06/2013
1	Interleukin-13IBA 06/2013
1	beta CateninIBA 03/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012
1	ChromatinIBA 02/2012
1	TCF Transcription FactorsIBA 10/2011
1	Annexin A5IBA 10/2011
1	thiazolyl blueIBA 10/2011
1	Antineoplastic Agents (Antineoplastics)IBA 10/2011
1	Transcription Factor 4IBA 06/2011
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2010
1	ErbB Receptors (EGF Receptor)IBA 09/2010
1	Complementary DNA (cDNA)IBA 09/2010
1	Protein Isoforms (Isoforms)IBA 07/2010

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2011
3	Radiotherapy 04/2019 - 01/2014
1	Dry Powder Inhalers 01/2022
1	Personal Protective Equipment 11/2020
1	Blood Transfusion (Blood Transfusions) 10/2020